FDA Approves New Indication for Envarsus XR (tacrolimus extended-release tablets)

Article Link: FDA Approves New Indication for Envarsus XR (tacrolimus extended-release tablets)

COPENHAGEN, Denmark, Dec. 19, 2018 /PRNewswire/ — Veloxis Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) approved a new indication for Envarsus XR (tacrolimus extended-release tablets) to prevent organ rejection…

Source: FDA New Drug Approvals